Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor I genes

References

• Hemsley KM, King B, Hopwood JJ. Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPSIIIA mice. Mol Genet Metab. 2007;90:313–28.
   PubMed Web of Science ®Google Scholar
• Meng X-L, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type vii mouse. J Neurosci Res. 2003;74:266–77.
   PubMed Web of Science ®Google Scholar
• Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 1995;374:367–70.
   PubMed Web of Science ®Google Scholar
• Givogri MI, Galbiati F, Fasano S, Amadio S, Perani L, Superchi D, . Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci Res. 2006;26:3109–19.
   Google Scholar
• Kawabata K, Migita M, Mochizuki H, Miyake K, Igarashi T, Fukunaga Y, . Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Brain Res. 2006;1094:13–23.
   PubMed Web of Science ®Google Scholar
• Zhao G, McCarthy NF, Sheehy PA, Taylor RM. Comparison of the behavior of neural stem cells in the brain of normal and twitcher mice after neonatal transplantation. Stem Cells Devel. 2007;16:429–38.
   PubMed Web of Science ®Google Scholar
• Sawada T, Tanaka A, Higaki K, Takamura A, Nanba E, Seto T, . Intracerebral cell transplantation therapy for murine GM1 gangliosidosis. Brain Devel. 2008. doi: 10.1016/ j.rbraindev.2008.11.004
   Google Scholar
• Bhaumik M, Muller VJ, Rozaklis T, Johnson L, Dobrenis K, Bhattacharyya R, . A mouse model for mucopolysaccharidosis type IIIA (Sanfilippo syndrome). Glycobiol. 1999;9:1389–96.
   PubMed Web of Science ®Google Scholar
• Crawley AC, Gliddon BL, Auclair D, Brodie SL, Hirte C, King BM, . Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Res. 2006;1104:1–17.
   PubMed Web of Science ®Google Scholar
• Lau AA, Hemsley KM, Meedeniya A, Hopwood JJ. In vitro characterization of genetically modified embryonic stem cells as a therapy for murine mucopolysaccharidosis type IIIA. Mol Genet Metab. 2004;81:86–95.
   Google Scholar
• Robinson AR, Zhao G, Rathjen J, Rathjen PD, Hutchinson RG, Eyre HJ, . Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain. In press.
   Google Scholar
• Cosma MP, Pepe S, Annunziata I, Newbold RF, Grompe M, Parenti G, . The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Cell. 2003;113:445–56.
   PubMed Web of Science ®Google Scholar
• Dierks T, Schmidt B, Borissenko LV, Peng J, Preusser A, Mariappan M, . Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C (alpha)-formylglycine generating enzyme. Cell. 2003;113: 435–44.
   PubMed Web of Science ®Google Scholar
• Fraldi A, Biffi A, Lombardi A, Visigalli I, Pepe S, Settembre C, . SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies. Biochem J. 2007;403: 305–12.
   PubMed Web of Science ®Google Scholar
• Almeciga-Diaz CJ, Rueda-Paramo MA, Espejo AJ, Echeverri OY, Montano A, Tomatsu S, . Effect of elongation factor 1a promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase. Mol Biol Rep. 2008;36:1863–1870.
   Google Scholar
• Fraldi A, Hemsley K, Crawley A, Lombardi A, Lau A, Sutherland L, . Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Human Mol Gen. 2007;16:2693–702.
   PubMed Web of Science ®Google Scholar
• Hemsley KM, Beard H, King B, Hopwood JJ. Effect of high dose, repeated intra-CSF injection of sulphamidase on neuropathology in MPS IIIA mice. Genes Brain Behav. 2008;7:740–53.
   PubMed Web of Science ®Google Scholar
• Li Y, Horwitz MS. Use of green fluorescent protein in studies of apoptosis of transfected cells. Biotechniques. 1997;23: 1026–9.
   Google Scholar
• Yoon Y, Pitts K, McNiven M. Studying cytoskeletal dynamics in living cells using green fluorescent protein. Mol Biotechnol. 2002;21:241–50.
   Google Scholar
• Chan KK-K, Wu SM, Nissom PM, Oh SKW, Choo ABH. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system. Stem Cells Devel. 2008;17:825–36.
   PubMed Web of Science ®Google Scholar
• Wang R, Liang J, Jiang H, Qin L-J, Yang H-T. Promoter-dependent EGFP expression during embryonic stem cell propagation and differentiation. Stem Cells Devel. 2008;17:279–89.
   PubMed Web of Science ®Google Scholar
• Hopwood JJ, Elliott H. The diagnosis of the Sanfilippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity. Clin Chim Acta. 1982;112:67–75.
   Google Scholar
• Freshney RI. Characterization. Freshney RI. Culture of Animal Cells: a Manual of Basic Technique. 4th ed. Hoboken: Wiley-Liss; 2000. 229–257.
   Google Scholar
• Liu JW, Pernod G, Dunoyer-Geindre S, Fish RJ, Yang H, Bounameaux H, . Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells. 2006;24:199–208.
   Google Scholar
• Makrides SC. Components of vectors for gene transfer and expression in mammalian cells. Protein Exp Purif. 1999;17:183–202.
   PubMed Web of Science ®Google Scholar
• Chung S, Andersson T, Sonntag K-C, Bjorklund L, Isacson O, Kim K-S. Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells. 2002;20:139–45.
   PubMed Web of Science ®Google Scholar
• Ward CM, Stern PL. The human cytomegalovirus immediate-early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells. Stem Cells. 2002;20:472–5.
   PubMedGoogle Scholar
• Zeng X, Chen J, Sanchez JF, Coggiano M, Dillon-Carter O, Petersen J, . Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells. 2003;21:647–53.
   Google Scholar
• Robinson AJ, Crawley AC, Hopwood JJ. Over-expression of human lysosomal alpha-mannosidase in mouse embryonic stem cells. Mol Gen Metab. 2005;85:203–12.
   Google Scholar
• de Felipe P. Polycistronic viral vectors. Curr Gene Ther. 2002;2:355–78.
   PubMedGoogle Scholar
• Kim J-H, Do H-J, Choi S-J, Cho H-J, Park K-H, Yang H-M, . Efficient gene delivery in differentiated human embryonic stem cells. Exp Mol Med. 2005;37:36–44. Erratum appears in Exp Mol Med. 2006; 38:589.
   Google Scholar
• Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Comm. 1999;260:712–7.
   PubMed Web of Science ®Google Scholar
• Costa M, Dottori M, Ng E, Hawes SM, Sourris K, Jamshidi P, . The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nature Meth. 2005;2:259–60.
   PubMed Web of Science ®Google Scholar
• Liew C-G, Draper JS, Walsh J, Moore H, Andrews PW. Transient and stable transgene expression in human embryonic stem cells. Stem Cells. 2007;25:1521–8.
   PubMed Web of Science ®Google Scholar
• Swenson ES, Price JG, Brazelton T, Krause DS. Limitations of green fluorescent protein as a cell lineage marker. Stem Cells. 2007;25:2593–600.
   PubMed Web of Science ®Google Scholar
• Taghizadeh RR, Sherley JL. CFP and YFP, but not GFP, provide stable fluorescent marking of rat hepatic adult stem cells. J Biomed Biotechnol. 2008;2008:453–590.
   Google Scholar
• Laker C, Meyer J, Schopen A, Friel J, Heberlein C, Ostertag W, . Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol. 1998;72:339–48.
   PubMed Web of Science ®Google Scholar